Clinical trial
The Use of QUTENZA™ in Standard Clinical Practice: a Phase IV, Multicentre, European Non-interventional Study
NCT01737294 is registered in ClinicalTrials.gov with Astellas Pharma Europe Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Use of QUTENZA™ in Standard Clinical Practice: a Phase IV, Multicentre, European Non-interventional Study
- Lead sponsor
- Astellas Pharma Europe Ltd.
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 29, 2012
- Completion date
- August 31, 2014
- Enrollment
- 429 (actual)
- Sites
- 50
Conditions
As the registry lists them; a condition with its own page is linked.
peripheral neuropathic pain